News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>M Stanley Ratings, TPs on CN Biopharma Stocks (Table)
Stock | Rating | TP (HK$)EVEREST MED(01952.HK) | Equalweight | 55 -> 44INNOVENT BIO(01801.HK) | Overweight | 130VISEN PHARMA-B(02561.HK) | Overweight | 80 -> 50ZAI LAB(09688....
Reset
Send
The window will close in 5 seconds
<Research>M Stanley Ratings, TPs on CN Biopharma Stocks (Table)
Close
Recommend
12
Positive
18
Negative
9
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

Stock | Rating | TP (HK$)

EVEREST MED(01952.HK)  +0.200 (+0.493%)    Short selling $32.71M; Ratio 38.751%   | Equalweight | 55 -> 44
INNOVENT BIO(01801.HK)  +0.600 (+0.660%)    Short selling $398.18M; Ratio 95.618%   | Overweight | 130
VISEN PHARMA-B(02561.HK)  -0.200 (-0.801%)    Short selling $2.48K; Ratio 3.005%   | Overweight | 80 -> 50
ZAI LAB(09688.HK)  +0.630 (+4.158%)    Short selling $87.79M; Ratio 35.708%   | Overweight | 37.5 -> 19.5
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 16:25.)

Related News CMBI Slightly Raises TP for INNOVENT BIO (01801.HK) to HKD113.86, Accelerating Global Biopharmaceutical Transformation

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.